CDXS
Codexis, Inc. · NASDAQ
- Sector Process Industries
- Industry Chemicals: Specialty
- Website codexis.com
- Employees(FY) 248
- ISIN US1920051067
Performance
+4.03%
1W
+32.23%
1M
+13.52%
3M
+75.24%
6M
+18.36%
YTD
+30.32%
1Y
Profile
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Technical Analysis of CDXS 2024-05-10
Overview:
In analyzing the technical indicators for CDXS over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Anal...
Recent News & Updates
- 2024-05-13 18:00
- 2024-05-02 23:14
Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript(Yahoo Finance)
- 2024-05-02 18:47
Q1 2024 Codexis Inc Earnings Call(Yahoo Finance)
- 2024-05-02 16:01
- 2024-05-02 06:06
- 2024-05-02 05:34
Codexis: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-02 04:05
Codexis Reports First Quarter 2024 Financial Results(Globenewswire)
- 2024-04-18 04:05
- 2024-04-10 19:05
- 2024-02-28 21:40
Codexis, Inc. (NASDAQ:CDXS) Q4 2023 Earnings Call Transcript(Yahoo Finance)
- 2024-02-28 18:08
Q4 2023 Codexis Inc Earnings Call(Yahoo Finance)
- 2024-02-28 05:50
Codexis (CDXS) Tops Q4 Earnings and Revenue Estimates(Yahoo Finance)
- 2024-02-28 05:01
Codexis: Q4 Earnings Snapshot(Yahoo Finance)
- 2024-02-28 03:59
- 2024-02-28 03:05
- 2024-02-26 03:05
- 2024-02-25 19:05
- 2024-02-19 19:05
- 2024-02-14 03:05
- 2024-02-13 03:05
- 2024-02-01 03:05
- 2024-01-08 06:03
Baillie Gifford Trims Position in Codexis Inc(Yahoo Finance)
- 2023-12-26 19:30
- 2023-12-13 17:45
Aldevron signs agreement to acquire license to Codex HiCap RNA Polymerase(Pharmaceutical-business-review)
- 2023-12-13 03:06
- 2023-12-13 03:05
- 2023-12-10 18:05
- 2023-11-29 01:46
3 Synthetic Biology Stocks Likely to Mint New Millionaires(Yahoo Finance)
- 2023-11-28 03:05
- 2023-11-14 03:05
Page 1 of 4
previousnext